CA2081340A1 - Composition and method for topical treatment of damaged or diseased tissue - Google Patents

Composition and method for topical treatment of damaged or diseased tissue

Info

Publication number
CA2081340A1
CA2081340A1 CA002081340A CA2081340A CA2081340A1 CA 2081340 A1 CA2081340 A1 CA 2081340A1 CA 002081340 A CA002081340 A CA 002081340A CA 2081340 A CA2081340 A CA 2081340A CA 2081340 A1 CA2081340 A1 CA 2081340A1
Authority
CA
Canada
Prior art keywords
composition
use according
c3h6o
molecular weight
daltons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002081340A
Other languages
English (en)
French (fr)
Inventor
R. Martin Emanuele
Robert L. Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LadRx Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2081340A1 publication Critical patent/CA2081340A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002081340A 1990-04-26 1991-04-25 Composition and method for topical treatment of damaged or diseased tissue Abandoned CA2081340A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51350990A 1990-04-26 1990-04-26
US513,509 1990-04-26
US68703491A 1991-04-22 1991-04-22
US687,034 1991-04-22

Publications (1)

Publication Number Publication Date
CA2081340A1 true CA2081340A1 (en) 1991-10-27

Family

ID=27057898

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002081340A Abandoned CA2081340A1 (en) 1990-04-26 1991-04-25 Composition and method for topical treatment of damaged or diseased tissue

Country Status (10)

Country Link
EP (1) EP0526578A4 (ja)
JP (1) JPH0776175B2 (ja)
CN (1) CN1058341A (ja)
AU (1) AU647484B2 (ja)
BR (1) BR9106377A (ja)
CA (1) CA2081340A1 (ja)
IE (1) IE911403A1 (ja)
IL (1) IL97976A0 (ja)
PT (1) PT97504A (ja)
WO (1) WO1991016058A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
WO1997011096A1 (fr) * 1995-09-19 1997-03-27 Seikagaku Corporation Agent anti-inflammatoire
JP2001187740A (ja) * 2000-01-05 2001-07-10 Seikagaku Kogyo Co Ltd 創傷治療剤
FR2833268B1 (fr) * 2001-12-12 2005-07-08 Fabre Pierre Dermo Cosmetique Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
MX2020002288A (es) 2016-08-31 2020-07-14 Oji Holdings Corp Metodo de produccion para xilooligosacarido acido y xilooligosacarido acido.
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
JP6555431B2 (ja) * 2017-05-31 2019-08-07 王子ホールディングス株式会社 保湿外用剤
WO2019054344A1 (ja) 2017-09-12 2019-03-21 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
PT3730521T (pt) 2017-12-20 2023-06-19 Oji Holdings Corp Polissulfato de pentosano e medicamento contendo polissulfato de pentosano
CN111228466B (zh) * 2020-02-27 2023-06-27 温州医科大学 治疗糖尿病足的含氧气微泡的水凝胶及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor

Also Published As

Publication number Publication date
EP0526578A4 (en) 1993-09-22
CN1058341A (zh) 1992-02-05
PT97504A (pt) 1992-02-28
JPH05506861A (ja) 1993-10-07
AU647484B2 (en) 1994-03-24
JPH0776175B2 (ja) 1995-08-16
IL97976A0 (en) 1992-06-21
BR9106377A (pt) 1993-04-27
IE911403A1 (en) 1991-11-06
EP0526578A1 (en) 1993-02-10
AU7869291A (en) 1991-11-11
WO1991016058A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
AU647484B2 (en) Composition and method for topical treatment of damaged or diseased tissue
US20050214376A1 (en) Hydrogel-containing medical articles and methods of using and making the same
US4725609A (en) Method of promoting healing
EP2489338B1 (en) Dry wound dressing and drug delivery system
CA2409076A1 (en) Composition and method for growing, protecting, and healing tissues and cells
EP2292257A2 (en) Compositions and methods for dermatological wound healing
ES2361459A1 (es) Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo.
CN108158995A (zh) 一种含有壳聚糖的妇科用抗菌泡沫剂及其制备方法
CN114984301A (zh) 一种促进创面无瘢痕愈合的抗菌敷料及其制备方法
CA2247198C (en) Topical pharmaceutical composition containing heparin
CN111214694B (zh) 一种具有止血和加速伤口愈合功能的敷料及其制备方法
CN112933214A (zh) 一种促进伤口愈合的组合物
EP3585422B1 (en) Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
CN110198721B (zh) 含有聚乙烯吡咯烷酮和二巯基丙磺酸钠的抗菌组合物及其用途
WO2000030578A1 (en) Enzymatic treatment and prevention of hypertrophic skin
CN109674743B (zh) 一种伤口护理凝胶及其制备方法
CN110251716B (zh) 一种伤口护理用凝胶敷料及其制备方法
de Lima Dias Boaventura Muniz et al. Dressing systems based on chitosan as active transport platforms in the treatment of burnt skin: Mini‐review
Suzuki et al. Development of alginate gel dressing
CN113855849A (zh) 一种敷料组合物及其制备方法和应用
US20190192552A1 (en) Pharmaceutical compositions and methods for treating keloids, hypertrophic scars and wounds, and for providing improved skin care
CN113855850A (zh) 一种敷料组合物及其制备方法和应用
CA2390841A1 (en) Drug preparations
CA2069027A1 (en) Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
CN114732941A (zh) 一种清洁抑菌凝胶的制备方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued